Skip to content

Vaxcyte, Inc. PCVX FX Effect on Cash

FX Effect on Cash at other companies

Pfizer logo
PfizerPFE
$19M+371%
Merck & Co. logo
Merck & Co.MRK
-$19M-112%
Moderna logo
ModernaMRNA
$1M
Krystal Biotech, Inc. logo
Krystal Biotech, Inc.KRYS
-$1.33M-878%
ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX
$122K+1,320%
Vertex Pharmaceuticals logo
Vertex PharmaceuticalsVRTX
-$40.3M-232%

Other financials

Income statement

See full
Operating income-$345.9M-91.3%
Net income-$320.6M-128%
EPS (diluted)-$2.30-121%

Balance sheet

See full
Cash & equivalents$262.3M-24.7%
Total debt$116.3M+33.5%
Total equity$3.0B-6.4%
Total assets$3.3B-0.9%

Cash flow

See full
Operating cash flow-$280.6M-68.8%
CapEx$2.1M-61.2%
Free cash flow-$282.7M-64.7%

Valuation

See full
Market cap$7.43B+72.0%
Enterprise value$7.28B+78.6%

Returns & leverage

See full
Return on equity-30.6%+37.9pp
Debt / equity0.0×
Current ratio7.5×-10.2×

Where this comes from

Reported directly by Vaxcyte, Inc. in its filing.

Tagged under the XBRL concept us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.

The official record: Vaxcyte, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Vaxcyte, Inc.'s fx effect on cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Vaxcyte, Inc.'s FX effect on cash?
Vaxcyte, Inc. (PCVX) reported FX effect on cash of -$664K in Q1 2026.
How has Vaxcyte, Inc.'s FX effect on cash changed year-over-year?
Vaxcyte, Inc.'s FX effect on cash decreased by 156.7% year-over-year, from $1.17M to -$664K.
What is the long-term trend for Vaxcyte, Inc.'s FX effect on cash?
Over 3 years (2021 to 2025), Vaxcyte, Inc.'s FX effect on cash has grown at a 77.1% compound annual growth rate (CAGR), from -$439K to $2.44M.
What does FX effect on cash mean?
The impact of exchange rate changes on the value of cash and equivalents held in foreign currencies.